These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 10830342)

  • 1. Are the triptans for migraine therapy worth the cost?
    Becker WJ
    Can J Neurol Sci; 2000 May; 27(2):111-5. PubMed ID: 10830342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subcutaneous sumatriptan compared with usual acute treatments for migraine: clinical and pharmacoeconomic evaluation.
    Laloux P; Vakaet A; Monseu G; Jacquy J; Bourgeois P; van der Linden C
    Acta Neurol Belg; 1998 Dec; 98(4):332-41. PubMed ID: 9922821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost savings in migraine associated with less chest pain on new triptan therapy.
    Wang JT; Barr CE; Torigoe Y; Wang E; Rowland CR; Goldfarb SD
    Am J Manag Care; 2002 Feb; 8(3 Suppl):S102-7. PubMed ID: 11859905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical pharmacology of triptans].
    Sénard JM
    Rev Neurol (Paris); 2000; 156 Suppl 4():4S75-8. PubMed ID: 11139753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Economic analysis of triptan therapy for acute migraine: a Medicaid perspective.
    Mullins CD; Subedi PR; Healey PJ; Sanchez RJ
    Pharmacotherapy; 2007 Aug; 27(8):1092-101. PubMed ID: 17655509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Almotriptan versus sumatriptan in migraine treatment: direct medical costs of managing adverse chest symptoms.
    Mannix LK; Adelman JU; Goldfarb SD; Von S; Kozma CM
    Am J Manag Care; 2002 Feb; 8(3 Suppl):S94-101. PubMed ID: 11859910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current concepts of migraine and its treatment.
    Dahlöf CG
    Neurologia; 1999 Feb; 14(2):67-77. PubMed ID: 10100422
    [No Abstract]   [Full Text] [Related]  

  • 8. Fixed-dose sumatriptan and naproxen in poor responders to triptans with a short half-life.
    Mathew NT; Landy S; Stark S; Tietjen GE; Derosier FJ; White J; Lener SE; Bukenya D
    Headache; 2009 Jul; 49(7):971-82. PubMed ID: 19486178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [New triptan preparations can help the migraine patient. Pharmacodynamic and pharmacokinetic progresses].
    Dahlöf CG
    Lakartidningen; 1998 Nov; 95(46):5175, 5178-82, 5184-6. PubMed ID: 9842191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A systematic review of the use of triptans in acute migraine.
    Pham B
    Can J Neurol Sci; 2001 Aug; 28(3):272. PubMed ID: 11513349
    [No Abstract]   [Full Text] [Related]  

  • 11. Health outcomes evaluations: estimating the impact of almotriptan in managed care settings.
    Mayo KW; Osterhaus JT
    Am J Manag Care; 2002 Feb; 8(3 Suppl):S85-93. PubMed ID: 11859909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic benefit of eletriptan compared to sumatriptan for the acute relief of migraine pain--results of a model-based meta-analysis that accounts for encapsulation.
    Mandema JW; Cox E; Alderman J
    Cephalalgia; 2005 Sep; 25(9):715-25. PubMed ID: 16109054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cost effectiveness of treatment with triptanes in Spain].
    Gracia Naya M
    Rev Neurol; 2001 Nov 16-30; 33(10):921-4. PubMed ID: 11785001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Which triptan is best? Rating of triptans in migraine treatment].
    Diener HC
    Pharm Unserer Zeit; 2002; 31(5):462-9. PubMed ID: 12369164
    [No Abstract]   [Full Text] [Related]  

  • 15. Have the triptans fulfilled their promise?
    Lance JW
    J Clin Neurosci; 2001 Sep; 8(5):478. PubMed ID: 11535027
    [No Abstract]   [Full Text] [Related]  

  • 16. Have the triptans fulfilled their promise?
    Heywood J
    J Clin Neurosci; 2001 Sep; 8(5):477-8. PubMed ID: 11535026
    [No Abstract]   [Full Text] [Related]  

  • 17. [Probabilistic cost-effectiveness analysis of oral eletriptan in the treatment of acute migraine in Portugal].
    Félix JM; Inês MS; Acosta CM
    Acta Med Port; 2005; 18(1):77-87. PubMed ID: 16202337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute drug treatment of migraine attack.
    Narbone MC; Abbate M; Gangemi S
    Neurol Sci; 2004 Oct; 25 Suppl 3():S113-8. PubMed ID: 15549517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Almotriptan: meeting today's needs in acute migraine treatment.
    Láinez MJ
    Expert Rev Neurother; 2007 Dec; 7(12):1659-73. PubMed ID: 18052762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [New potent serotonin receptor agonist. Helps migraine patients even when other triptans fail].
    Einecke D
    MMW Fortschr Med; 2001 Jul; 143(26-27):60. PubMed ID: 11481924
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.